Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA
Most of these studies have a combined predefined endpoint of the classical MACE-3 (major adverse cardiovascular endpoint) consisting of cardiovascular death, non-fatal myocardial infarct and non-fatal stroke
Principal Scientist, Regeneron, Jay Caplan, President and Founder, Fractyl Health, Jerry Colca, Chief Scientific Officer, Cirius Therapeutics, Johan Fredrik Paulsson, Director Incretin and Amylin Biology, Novo Nordisk, Mina Sooch, Founder and General Partner, Apjohn Ventures, Scott Harris, Chief Medical Officer, Altimmune, Zohar Barbash, Chief Technology Officer, Lembas Bio Saturday, Aug 01, 2026 6:00p John F
The analysis revealed significant changes in gut microbiome diversity, with specific microbial genera such as Akkermansia, Christensenella, and Oscillospiraceae associated with reductions in BMI
This does not necessarily make the medication toxic, but it does make it less effective
1: S48 Abdenur JE, Chamoles NA, Guinle AE, et al
